<table cellpadding="0pt" id="_RefID70" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2: Rifabutin Interaction Studies</caption>
<col width="13%"></col>
<col width="13%"></col>
<col width="10%"></col>
<col width="9%"></col>
<col width="14%"></col>
<col width="14%"></col>
<col width="25%"></col>
<tfoot>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">↑ indicates increase; ↓ indicates decrease; ↔ indicates no significant change</td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">QD-once daily; BID-twice daily; TID – thrice daily</td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">ND -No Data</td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">AUC -Area under the Concentration vs. Time Curve; C
            
    
     <sub>max</sub> -Maximum serum concentration
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>a </sup>compared to rifabutin 300 mg QD alone
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>b </sup>compared to historical control (fosamprenavir/ritonavir 700/100 mg BID)
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>c </sup>also taking zidovudine 500 mg QD
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>d </sup>compared to rifabutin 150 mg QD alone
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>e </sup>compared to rifabutin 300 mg QD alone
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>f </sup>data from a case report
           
   
    </td>
</tr>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">
<sup>g </sup>compared to voriconazole 200 mg BID alone
           
   
    </td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Coadministered
              
      
       <br/>drug
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Dosing regimen
              
      
       <br/>of coadministered
              
      
       <br/>drug
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Dosing
              
      
       <br/>regimen of
              
      
       <br/>rifabutin
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Study
              
      
       <br/>population
              
      
       <br/>(n)
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Effect on
              
      
       <br/>rifabutin
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Effect on
              
      
       <br/>coadministered
              
      
       <br/>drug
             
     
      </content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Recommendation</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">ANTIVIRALS</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Amprenavir</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>1200 mg BID x
             
     
      <br/>10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy male
             
     
      <br/>subjects (6)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 193%,
             
     
      <br/>↑ C
             
     
      <sub>max </sub>by 119%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>50%. Monitor closely for adverse
             
     
      <br/>reactions.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Delavirdine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>400 mg TID</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (7)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 230%,
             
     
      <br/>↑ C
             
     
      <sub>max </sub>by 128%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 80%,
             
     
      <br/>↓ Cmax by 75%,
             
     
      <br/>↓ C
             
     
      <sub>min </sub>by 17%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">CONTRAINDICATED</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Didanosine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>167 or 250 mg BID
             
     
      <br/>x 12 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 or 600
             
     
      <br/>mg QD x 1
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (11)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Fosamprenavir/
             
     
      <br/>ritonavir
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>700 mg BID plus
             
     
      <br/>ritonavir 100 mg
             
     
      <br/>BID x 2 weeks
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg
             
     
      <br/>every other
             
     
      <br/>day x 2 weeks
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (15)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔ AUC
             
     
      <sup>a </sup>
<br/>↓ C
             
     
      <sub>max</sub> by 15%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 35%
             
     
      <sup>b</sup>,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 36%,
             
     
      <br/>↑ C
             
     
      <sub>min</sub> by 36%
             
     
      <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>75% (to a maximum 150 mg every
             
     
      <br/>other day or three times per week)
             
     
      <br/>when given with fosamprenavir/
             
     
      <br/>ritonavir combination.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Indinavir</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>800 mg TID
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (10)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 173%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 134%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 34%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 25%,
             
     
      <br/>↓ C
             
     
      <sub>min</sub> by 39%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by 50%, and
             
     
      <br/>increase indinavir dose from 800 mg
             
     
      <br/>to 1000 mg TID.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Lopinavir/
             
     
      <br/>ritonavir
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>400/100 mg BID
             
     
      <br/>x 20 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg QD
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (14)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 203%
             
     
      <sup>c</sup>
<br/>↓ C
             
     
      <sub>max</sub> by 112%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>75% (to a maximum 150 mg every
             
     
      <br/>other day or three times per week)
             
     
      <br/>when given with lopinavir/ritonavir
             
     
      <br/>combination. Monitor closely for
             
     
      <br/>adverse reactions. Reduce rifabutin
             
     
      <br/>dosage further, as needed.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Saquinavir/
             
     
      <br/>ritonavir
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>1000/100 mg BID
             
     
      <br/>x 14 or 22 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg every
             
     
      <br/>3 days X 21 to
             
     
      <br/>22 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 53% 
             
     
      <sup>d</sup>
<br/>↑ C
             
     
      <sub>max</sub> by 88% (n=11)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 13%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 15%,
             
     
      <br/>(n=19)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>75% (to a maximum 150 mg every
             
     
      <br/>other day or three times per week)
             
     
      <br/>when given with saquinavir/ritonavir
             
     
      <br/>combination. Monitor closely for
             
     
      <br/>adverse reactions.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Ritonavir</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>500 mg BID
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg QD
             
     
      <br/>x 16 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (5)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 300%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 150%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>75% (to a maximum 150 mg every
             
     
      <br/>other day or three times per week)
             
     
      <br/>when given with lopinavir/ritonavir
             
     
      <br/>combination. Monitor closely for
             
     
      <br/>adverse reactions. Reduce rifabutin
             
     
      <br/>dosage further, as needed.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Tipranavir/
             
     
      <br/>ritonavir
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>500/200 BID
             
     
      <br/>X 15 doses
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg
             
     
      <br/>single dose
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (20)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 190%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 70%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by at least
             
     
      <br/>75% (to a maximum 150 mg every
             
     
      <br/>other day or three times per week)
             
     
      <br/>when given with tipranavir/ritonavir
             
     
      <br/>combination. Monitor closely for
             
     
      <br/>adverse reactions. Reduce rifabutin
             
     
      <br/>dosage further, as needed.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Nelfinavir</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>1250 mg BID
             
     
      <br/>x 7 to 8 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>150 mg QD
             
     
      <br/>x 8 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (11)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 83%,
             
     
      <sup>e</sup>
<br/>↑ C
             
     
      <sub>max</sub> by 19%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Reduce rifabutin dose by 50%
             
     
      <br/>(to 150 mg QD) and increase the
             
     
      <br/>nelfinavir dose to 1250 mg BID
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Zidovudine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>100 or 200 mg
             
     
      <br/>q4h
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 or 450
             
     
      <br/>mg QD
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (16)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 32%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 48%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Because zidovudine levels remained
             
     
      <br/>within the therapeutic range during
             
     
      <br/>coadministration of rifabutin, dosage
             
     
      <br/>adjustments are not necessary.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">ANTIFUNGALS</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Fluconazole</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>200 mg QD
             
     
      <br/>x 2 weeks
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>x 2 weeks
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (12)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 82%,
             
     
      <br/>↑C
             
     
      <sub>max</sub> by 88%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Monitor for rifabutin associated
             
     
      <br/>adverse events. Reduce rifabutin
             
     
      <br/>dose or suspend rifabutin use if
             
     
      <br/>toxicity is suspected.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Posaconazole</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>200 mg QD
             
     
      <br/>x 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>x 17 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (8)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 72%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 31%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 49%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 43%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>If co-administration of these two
             
     
      <br/>drugs cannot be avoided, patients
             
     
      <br/>should be monitored for adverse
             
     
      <br/>events associated with rifabutin
             
     
      <br/>administration, and lack of
             
     
      <br/>posaconazole efficacy.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Itraconazole</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>200 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-Infected
             
     
      <br/>patients (6)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑
             
     
      <sup>f</sup>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 70%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 75%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>If co-administration of these two
             
     
      <br/>drugs cannot be avoided, patients
             
     
      <br/>should be monitored for adverse
             
     
      <br/>events associated with rifabutin
             
     
      <br/>administration, and lack of
             
     
      <br/>itraconazole efficacy. In a separate
             
     
      <br/>study, one case of uveitis was
             
     
      <br/>associated with increased serum
             
     
      <br/>rifabutin levels following
             
     
      <br/>coadministration of rifabutin
             
     
      <br/>(300 mg QD) with itraconazole
             
     
      <br/>(600 to 900 mg QD).
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Voriconazole</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>400 mg BID
             
     
      <br/>x 7 days
             
     
      <br/>(maintenance
             
     
      <br/>dose)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>x 7 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy male
             
     
      <br/>subjects (12)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 331%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by 195%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by ~100%,
             
     
      <br/>↑ C
             
     
      <sub>max</sub> by ~100%
             
     
      <sup>g</sup>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">CONTRAINDICATED</content>
</paragraph>
</td>
</tr>
<tr>
<td colspan="3" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">ANTI-PCP (Pneumocystis carinii pneumonia)</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Dapsone</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>50 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (16)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 27 to 40%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Sulfamethoxazole
             
     
      <br/>-Trimethoprim
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>800/160 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (12)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 15 to 20%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td colspan="6" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">ANTI-MAC (Mycobacterium avium intracellulare complex)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Azithromycin</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>500 mg QD
             
     
      <br/>x 1 day, then
             
     
      <br/>250 mg QD
             
     
      <br/>x 9 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (6)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Clarithromycin</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>500 mg BID</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (12)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ AUC by 75%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ AUC by 50%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Monitor for rifabutin associated
             
     
      <br/>adverse events. Reduce dose or
             
     
      <br/>suspend use of rifabutin if toxicity
             
     
      <br/>is suspected. Alternative treatment
             
     
      <br/>for clarithromycin should be considered
             
     
      <br/>when treating patients receiving rifabutin
            
    
     </paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">ANTI-TB (Tuberculosis)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Ethambutol</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>1200 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>X 7 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects(10)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Isoniazid</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>X 7 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (6)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">OTHER</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Methadone</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>20 to 100
             
     
      <br/>mg QD
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>X 13 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>HIV-infected
             
     
      <br/>patients (24)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Ethinylestradiol (EE)/
             
     
      <br/>Norethindrone (NE)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>35 mg EE /
             
     
      <br/>1 mg NE
             
     
      <br/>X 21 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>300 mg QD
             
     
      <br/>X 10 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Healthy female
             
     
      <br/>subjects (22)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>EE: ↓ AUC by 35%,
             
     
      <br/>↓ C
             
     
      <sub>max</sub> by 20%
             
     
      <br/>NE: ↓ AUC by 46%
            
    
     </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Patients should be advised to use
             
     
      <br/>additional or alternative methods
             
     
      <br/>of contraception.
            
    
     </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Theophylline</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>5 mg/kg</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>300 mg
             
     
      <br/>X 14 days
            
    
     </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Healthy
             
     
      <br/>subjects (11)
            
    
     </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>ND</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top"></td>
</tr>
</tbody>
</table>